Valerie Sapozhnikova

Associate
Full contact info

Experience

Cooley Advises Life360 on $178.5 Million IPO

June 7, 2024

Cooley advised Life360, a family connection and safety company, on its $178.5 million initial public offering.

Read more

Related contacts

C. Thomas Hopkins
Partner, Los Angeles Santa Monica
David Peinsipp
Partner, San Francisco
Siana Lowrey
Of Counsel
Natalie Karam
Partner, Palo Alto
Alexander Gefter
Associate, Los Angeles Santa Monica
Jaleel Chandler
Associate, Los Angeles Santa Monica
Baasit Bhutta
Associate, Colorado
Michael Aridi Barake
Associate, Los Angeles Santa Monica
Grady Chang
Associate, Los Angeles Santa Monica
Steven Holm
Associate, Singapore
Valerie Sapozhnikova
Associate, Los Angeles Downtown
Samara Zaifman
Associate, Palo Alto
Ryan Lewis
Associate, Colorado
Alanna Anderson
Associate, Palo Alto
Krina Desai
Associate, Palo Alto
Kristine Kevorkova
Associate, Los Angeles Santa Monica
Reid Hooper
Special Counsel, Washington, DC
Justin Kisner
Special Counsel, Palo Alto
Alessandra Murata
Partner, Palo Alto
Ajay Athavale
Associate, San Francisco
Travis LeBlanc
Partner, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Mari Dugas
Associate, Washington, DC
Todd Gluth
Partner, San Diego
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Rick Jantz
Associate, Los Angeles Santa Monica
Ross Eberly
Partner, Los Angeles Santa Monica
Rebecca Ross
Special Counsel, Washington, DC
Francis Wheeler
Partner, Colorado
Mischi a Marca
Partner, San Francisco
Brian Youn
Paralegal Specialist, Palo Alto
Melanie Yuvienco
Paralegal Specialist, Palo Alto

Related Practices & Industries

Cidara Therapeutics Announces Concurrent Reacquisition of IP Rights to CD388, $240 Million PIPE Financing

May 1, 2024

Cooley advised Cidara Therapeutics (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak platform to develop drug-Fc conjugate immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, on its concurrent $240 million private placement financing and definitive agreement with Janssen Pharmaceuticals, a Johnson & Johnson Company, to reacquire the exclusive global development and commercial rights to CD388.

Read more

Related contacts

Charles Bair
Partner, San Diego
Jane Adams
Partner, San Diego
Barbara Borden
Partner, San Diego
Megan Browdie
Partner, Washington, DC
Daniel I. Goldberg
Partner, New York
Aaron Pomeroy
Partner, Colorado
Richard Segal
Partner, New York
Francis Wheeler
Partner, Colorado
Sharon Connaughton
Special Counsel, Washington, DC
Asa Henin
Special Counsel, San Diego
Alexis Guillermo Buz
Associate, San Diego
Gaël Y. Hagan
Associate, Colorado
Michelle Hunt
Associate
Edmond Lay
Associate, San Diego
Kyrsten Lundh
Associate, San Diego
Jayden Martinez
Associate, Colorado
Amanda Pacheco
Associate, Palo Alto
Valerie Sapozhnikova
Associate, Los Angeles Downtown
Kelly Nelle
Paralegal Specialist, San Diego

Related Practices & Industries

Viking Therapeutics Announces $632.5 Million Public Offering of Common Stock

March 4, 2024

Cooley advised the underwriters of Viking Therapeutics – a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders – on its $632.5 million public offering of common stock.

Read more

Related contacts

Denny Won
Partner, San Francisco
Kristin VanderPas
Partner, San Francisco
Charlie Kim
Partner, San Diego
David Peinsipp
Partner, San Francisco
Valerie Sapozhnikova
Associate, Los Angeles Downtown
Madison (JJ) Meng
Associate, San Francisco
Peter A. Haddad
Associate, San Diego
Natasha Leskovsek
Of Counsel, Washington, DC
Phil Mitchell
Partner, New York
Wyatt Kernell
Associate, Colorado
Madhuri Roy
Partner, Palo Alto
Randy Sabett
Special Counsel, Washington, DC
Rebecca Ross
Special Counsel, Washington, DC
Xander Lee
Partner, Los Angeles Santa Monica

Related Practices & Industries

Cooley Advises Lantheus on Concurrent PIPE Investment, Partnering Transaction, Asset Sale With Perspective Therapeutics

January 9, 2024

Cooley advised Lantheus Holdings, a top publicly traded radiopharmaceutical-focused company, on a concurrent private investment in public equity (PIPE) transaction, partnering transaction and asset sale with Perspective Therapeutics.

Read more

Related contacts

Div Gupta
Partner, New York
Geoffrey Spolyar
Partner, Boston
Bill Roegge
Partner, New York
Ritu Gupta
Special Counsel, New York
Zachary Sonenshine
Associate, New York
Valerie Sapozhnikova
Associate, Los Angeles Downtown
Eileen Marshall
Partner, Washington, DC
Sarah Buchik
Associate, New York

Related Practices & Industries

RayzeBio Announces Upsized $357.6 Million IPO

September 19, 2023

Cooley advised RayzeBio, a targeted radiopharmaceutical company developing an innovative pipeline against solid tumor targets, on its upsized $357.6 million initial public offering.

Read more

Related contacts

Carlos Ramirez
Partner, San Diego
Charlie Kim
Partner, San Diego
Marya Postner
Partner, Palo Alto
Terren O'Connor
Associate, San Diego
Valerie Sapozhnikova
Associate, Los Angeles Downtown
Jayden Martinez
Associate, Colorado
Michelle Hunt
Associate
Todd Gluth
Partner, San Diego
Tony P. Guan
Associate, Los Angeles Santa Monica
Nathaniel Hearn Jr.
Associate, Chicago
Natasha Leskovsek
Of Counsel, Washington, DC
Phil Mitchell
Partner, New York
Alessandra Murata
Partner, Palo Alto
Kelly Nelle
Paralegal Specialist, San Diego
Rebecca Ross
Special Counsel, Washington, DC
Jennifer Shanley
Special Counsel, New York
Jeffrey J. Tolin
Partner, New York
Francis Wheeler
Partner, Colorado

Related Practices & Industries

View more

Admissions and credentials

New York

California